

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemoglobin metabolic process (GO:0020027) | 7.62127819 |
| 2 | oxygen transport (GO:0015671) | 6.55714983 |
| 3 | heme biosynthetic process (GO:0006783) | 5.77759405 |
| 4 | gas transport (GO:0015669) | 5.44657437 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.27118798 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.27118798 |
| 7 | tetrapyrrole biosynthetic process (GO:0033014) | 5.19883982 |
| 8 | coenzyme catabolic process (GO:0009109) | 5.16509221 |
| 9 | cellular ketone body metabolic process (GO:0046950) | 5.14133525 |
| 10 | porphyrin-containing compound metabolic process (GO:0006778) | 5.12239995 |
| 11 | heme metabolic process (GO:0042168) | 5.03710541 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.00454106 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 5.00454106 |
| 14 | erythrocyte development (GO:0048821) | 4.89988856 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.87021218 |
| 16 | microglial cell activation (GO:0001774) | 4.77727195 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.74295889 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.74295889 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.74295889 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.74295889 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.74295889 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.74295889 |
| 23 | lysine metabolic process (GO:0006553) | 4.71666807 |
| 24 | lysine catabolic process (GO:0006554) | 4.71666807 |
| 25 | aromatic amino acid family catabolic process (GO:0009074) | 4.67332519 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.60931148 |
| 27 | negative regulation of cell killing (GO:0031342) | 4.58548748 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.58548748 |
| 29 | erythrocyte maturation (GO:0043249) | 4.51608108 |
| 30 | cysteine metabolic process (GO:0006534) | 4.51227177 |
| 31 | glyoxylate metabolic process (GO:0046487) | 4.48703666 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 4.44051075 |
| 33 | ketone body metabolic process (GO:1902224) | 4.39454695 |
| 34 | kynurenine metabolic process (GO:0070189) | 4.35399208 |
| 35 | heme transport (GO:0015886) | 4.21751517 |
| 36 | bile acid biosynthetic process (GO:0006699) | 4.14998314 |
| 37 | alpha-linolenic acid metabolic process (GO:0036109) | 4.11705251 |
| 38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.11178240 |
| 39 | tryptophan catabolic process (GO:0006569) | 4.08996344 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 4.08996344 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 4.08996344 |
| 42 | acetyl-CoA metabolic process (GO:0006084) | 4.08618627 |
| 43 | positive regulation of granulocyte differentiation (GO:0030854) | 4.06643723 |
| 44 | cellular modified amino acid catabolic process (GO:0042219) | 4.00326177 |
| 45 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.98863549 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.98387108 |
| 47 | carnitine shuttle (GO:0006853) | 3.98371937 |
| 48 | fatty acid transmembrane transport (GO:1902001) | 3.97532333 |
| 49 | cofactor catabolic process (GO:0051187) | 3.97219362 |
| 50 | negative regulation of necroptotic process (GO:0060546) | 3.94245190 |
| 51 | myeloid cell development (GO:0061515) | 3.94066506 |
| 52 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.89737173 |
| 53 | regulation of platelet aggregation (GO:0090330) | 3.88834308 |
| 54 | ethanol oxidation (GO:0006069) | 3.86100123 |
| 55 | short-chain fatty acid metabolic process (GO:0046459) | 3.85047077 |
| 56 | hepatocyte apoptotic process (GO:0097284) | 3.84984388 |
| 57 | regulation of necroptotic process (GO:0060544) | 3.83996374 |
| 58 | neutrophil activation involved in immune response (GO:0002283) | 3.83759800 |
| 59 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.82875454 |
| 60 | aspartate family amino acid catabolic process (GO:0009068) | 3.81277973 |
| 61 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.79452391 |
| 62 | detection of external biotic stimulus (GO:0098581) | 3.77198413 |
| 63 | response to methylmercury (GO:0051597) | 3.72752572 |
| 64 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.72551364 |
| 65 | regulation of triglyceride catabolic process (GO:0010896) | 3.72195682 |
| 66 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.68165544 |
| 67 | tryptophan metabolic process (GO:0006568) | 3.66524683 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.64218707 |
| 69 | detection of other organism (GO:0098543) | 3.63792207 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63205169 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 3.61701913 |
| 72 | biotin metabolic process (GO:0006768) | 3.59999022 |
| 73 | neutrophil mediated immunity (GO:0002446) | 3.59077829 |
| 74 | nucleobase catabolic process (GO:0046113) | 3.56607576 |
| 75 | regulation of response to osmotic stress (GO:0047484) | 3.56461089 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.54136752 |
| 77 | response to host immune response (GO:0052572) | 3.54136752 |
| 78 | amino-acid betaine metabolic process (GO:0006577) | 3.54102507 |
| 79 | urea metabolic process (GO:0019627) | 3.53260331 |
| 80 | urea cycle (GO:0000050) | 3.53260331 |
| 81 | peroxisome fission (GO:0016559) | 3.51976851 |
| 82 | macrophage activation (GO:0042116) | 3.46725710 |
| 83 | alpha-amino acid catabolic process (GO:1901606) | 3.46651152 |
| 84 | cellular amino acid catabolic process (GO:0009063) | 3.42867472 |
| 85 | tricarboxylic acid cycle (GO:0006099) | 3.42343432 |
| 86 | negative regulation of fibrinolysis (GO:0051918) | 3.42015054 |
| 87 | epoxygenase P450 pathway (GO:0019373) | 3.40004304 |
| 88 | regulation of sequestering of triglyceride (GO:0010889) | 3.39661106 |
| 89 | fatty acid beta-oxidation (GO:0006635) | 3.39272750 |
| 90 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.38548379 |
| 91 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.38029625 |
| 92 | glutamate metabolic process (GO:0006536) | 3.37597754 |
| 93 | regulation of fibrinolysis (GO:0051917) | 3.36949972 |
| 94 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.36578330 |
| 95 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.36432364 |
| 96 | nitrogen cycle metabolic process (GO:0071941) | 3.36366646 |
| 97 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.35286829 |
| 98 | bile acid metabolic process (GO:0008206) | 3.35256685 |
| 99 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.35068116 |
| 100 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.32845255 |
| 101 | fatty acid oxidation (GO:0019395) | 3.30940565 |
| 102 | fatty acid catabolic process (GO:0009062) | 3.30635771 |
| 103 | branched-chain amino acid catabolic process (GO:0009083) | 3.29805264 |
| 104 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.28692251 |
| 105 | regulation of protein activation cascade (GO:2000257) | 3.28483392 |
| 106 | cellular hyperosmotic response (GO:0071474) | 3.26249691 |
| 107 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25330675 |
| 108 | macrophage activation involved in immune response (GO:0002281) | 3.25328823 |
| 109 | complement activation, alternative pathway (GO:0006957) | 3.24169606 |
| 110 | lipid oxidation (GO:0034440) | 3.22556181 |
| 111 | definitive hemopoiesis (GO:0060216) | 3.21916328 |
| 112 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.19992809 |
| 113 | aromatic amino acid family metabolic process (GO:0009072) | 3.19557018 |
| 114 | cellular response to epinephrine stimulus (GO:0071872) | 3.19391511 |
| 115 | positive regulation of receptor recycling (GO:0001921) | 3.19367833 |
| 116 | monocarboxylic acid catabolic process (GO:0072329) | 3.19361509 |
| 117 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.18988496 |
| 118 | detection of bacterium (GO:0016045) | 3.17800167 |
| 119 | detection of biotic stimulus (GO:0009595) | 3.16543751 |
| 120 | flavonoid metabolic process (GO:0009812) | 3.16237697 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16125985 |
| 122 | amino-acid betaine transport (GO:0015838) | 3.15536622 |
| 123 | carnitine transport (GO:0015879) | 3.15536622 |
| 124 | carnitine transmembrane transport (GO:1902603) | 3.15246452 |
| 125 | response to host defenses (GO:0052200) | 3.13969608 |
| 126 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.13969608 |
| 127 | response to host (GO:0075136) | 3.13969608 |
| 128 | carboxylic acid catabolic process (GO:0046395) | 3.13641626 |
| 129 | organic acid catabolic process (GO:0016054) | 3.13641626 |
| 130 | tetrapyrrole metabolic process (GO:0033013) | 3.13187609 |
| 131 | cellular extravasation (GO:0045123) | 3.12504467 |
| 132 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12112216 |
| 133 | negative regulation of necrotic cell death (GO:0060547) | 3.09392092 |
| 134 | drug catabolic process (GO:0042737) | 3.08761755 |
| 135 | daunorubicin metabolic process (GO:0044597) | 3.06920134 |
| 136 | polyketide metabolic process (GO:0030638) | 3.06920134 |
| 137 | doxorubicin metabolic process (GO:0044598) | 3.06920134 |
| 138 | drug metabolic process (GO:0017144) | 3.05327151 |
| 139 | quaternary ammonium group transport (GO:0015697) | 3.04200220 |
| 140 | regulation of complement activation (GO:0030449) | 3.03281619 |
| 141 | iron coordination entity transport (GO:1901678) | 3.03032768 |
| 142 | myeloid leukocyte mediated immunity (GO:0002444) | 3.02186537 |
| 143 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01575226 |
| 144 | acylglycerol homeostasis (GO:0055090) | 3.01463330 |
| 145 | triglyceride homeostasis (GO:0070328) | 3.01463330 |
| 146 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.98747661 |
| 147 | mitochondrion degradation (GO:0000422) | 2.98734939 |
| 148 | urate metabolic process (GO:0046415) | 2.96653256 |
| 149 | valine metabolic process (GO:0006573) | 2.96492053 |
| 150 | branched-chain amino acid metabolic process (GO:0009081) | 2.95566059 |
| 151 | response to peptidoglycan (GO:0032494) | 2.94725429 |
| 152 | carnitine metabolic process (GO:0009437) | 2.93223413 |
| 153 | thioester biosynthetic process (GO:0035384) | 2.92546195 |
| 154 | acyl-CoA biosynthetic process (GO:0071616) | 2.92546195 |
| 155 | protein carboxylation (GO:0018214) | 2.92087423 |
| 156 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.92087423 |
| 157 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.91769838 |
| 158 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.91769838 |
| 159 | regulation of cofactor metabolic process (GO:0051193) | 2.90867870 |
| 160 | regulation of coenzyme metabolic process (GO:0051196) | 2.90867870 |
| 161 | regulation of cholesterol esterification (GO:0010872) | 2.90215161 |
| 162 | quinone metabolic process (GO:1901661) | 2.89774985 |
| 163 | succinate metabolic process (GO:0006105) | 2.88731182 |
| 164 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.88683100 |
| 165 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.88521853 |
| 166 | megakaryocyte development (GO:0035855) | 2.88032597 |
| 167 | tyrosine metabolic process (GO:0006570) | 2.87050082 |
| 168 | plasma lipoprotein particle clearance (GO:0034381) | 2.86919367 |
| 169 | positive regulation of fatty acid oxidation (GO:0046321) | 2.86384908 |
| 170 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.84108620 |
| 171 | erythrocyte differentiation (GO:0030218) | 2.82628908 |
| 172 | regulation of granulocyte differentiation (GO:0030852) | 2.81486615 |
| 173 | regulation of receptor recycling (GO:0001919) | 2.80726791 |
| 174 | plasma lipoprotein particle assembly (GO:0034377) | 2.77955915 |
| 175 | neutrophil activation (GO:0042119) | 2.76884375 |
| 176 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75818834 |
| 177 | respiratory burst (GO:0045730) | 2.73946150 |
| 178 | regulation of necrotic cell death (GO:0010939) | 2.73923852 |
| 179 | cellular response to leptin stimulus (GO:0044320) | 2.73278621 |
| 180 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72845978 |
| 181 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72018881 |
| 182 | dopamine transport (GO:0015872) | 2.71416402 |
| 183 | positive regulation of B cell differentiation (GO:0045579) | 2.69563028 |
| 184 | B cell receptor signaling pathway (GO:0050853) | 2.68477213 |
| 185 | negative regulation of T cell mediated immunity (GO:0002710) | 2.66381133 |
| 186 | regulation of erythrocyte differentiation (GO:0045646) | 2.65339550 |
| 187 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.64811604 |
| 188 | response to epinephrine (GO:0071871) | 2.64238154 |
| 189 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.64107901 |
| 190 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.62817239 |
| 191 | positive regulation of response to oxidative stress (GO:1902884) | 2.62817239 |
| 192 | granulocyte differentiation (GO:0030851) | 2.59882272 |
| 193 | myeloid cell activation involved in immune response (GO:0002275) | 2.58615384 |
| 194 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.57858046 |
| 195 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.56876687 |
| 196 | dosage compensation (GO:0007549) | 2.56230881 |
| 197 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.56086750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.23723768 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 6.40334173 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.13698059 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.69109509 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.58139552 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.18085409 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.05972074 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.02892453 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.77318581 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.42196691 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.26610271 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.24424261 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.19430405 |
| 14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.98951846 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.97462806 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95155410 |
| 17 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.79362416 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.74635660 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73517403 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.58951879 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34691994 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31733079 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.29971394 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.29945668 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.22263628 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21416266 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19118156 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.16602831 |
| 29 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.14069763 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 2.13088127 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.12760028 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03160188 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03125491 |
| 34 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.02618133 |
| 35 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.97940482 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97388800 |
| 37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.94945277 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94661488 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91991788 |
| 40 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84768716 |
| 41 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.83104747 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.79746932 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79379558 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77359355 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75388804 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73901474 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.69671468 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.67950316 |
| 49 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67437768 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.64259334 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63558834 |
| 52 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.63106736 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62850501 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62698412 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.62444424 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58667830 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58596144 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58323741 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51902533 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51666760 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50064142 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49565989 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49292096 |
| 64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47443296 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43396957 |
| 66 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.43161893 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41703030 |
| 68 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39676160 |
| 69 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.38187039 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33592129 |
| 71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29393997 |
| 72 | VDR_22108803_ChIP-Seq_LS180_Human | 1.29344485 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26061247 |
| 74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25941147 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24995883 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23750384 |
| 77 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.23410185 |
| 78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.22888242 |
| 79 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.22888242 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22266608 |
| 81 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20502013 |
| 82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19943642 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19338967 |
| 84 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.18047705 |
| 85 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17585538 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17417679 |
| 87 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.17207453 |
| 88 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.15728101 |
| 89 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.13821745 |
| 90 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10949515 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10243030 |
| 92 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09910266 |
| 93 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.09526853 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08241493 |
| 95 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.08201774 |
| 96 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.07688815 |
| 97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07637299 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06926172 |
| 99 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06893225 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06644064 |
| 101 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.06636466 |
| 102 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06584804 |
| 103 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06375089 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05837596 |
| 105 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.04324755 |
| 106 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03670642 |
| 107 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03188985 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02605060 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01751581 |
| 110 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01747304 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00994441 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00752197 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00662255 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99377876 |
| 115 | MYC_22102868_ChIP-Seq_BL_Human | 0.97266674 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96041647 |
| 117 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95960369 |
| 118 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94669005 |
| 119 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93730685 |
| 120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93678057 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92841981 |
| 122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92610938 |
| 123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92475325 |
| 124 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92043188 |
| 125 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.92024501 |
| 126 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91448406 |
| 127 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91285130 |
| 128 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.91273527 |
| 129 | MAF_26560356_Chip-Seq_TH2_Human | 0.90427394 |
| 130 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90070415 |
| 131 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89731198 |
| 132 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89580229 |
| 133 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89366173 |
| 134 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89366173 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88919333 |
| 136 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88105703 |
| 137 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87202155 |
| 138 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.84595691 |
| 139 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84587679 |
| 140 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84400422 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83351353 |
| 142 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.81549885 |
| 143 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.80873740 |
| 144 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.80641458 |
| 145 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78934499 |
| 146 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78809850 |
| 147 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.75664300 |
| 148 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.75516185 |
| 149 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.75516185 |
| 150 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.75327948 |
| 151 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75271828 |
| 152 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73492479 |
| 153 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.73268593 |
| 154 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.72997295 |
| 155 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.72503417 |
| 156 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.71984889 |
| 157 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.71769848 |
| 158 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71677900 |
| 159 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.71527877 |
| 160 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.70930765 |
| 161 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.70897626 |
| 162 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.69337079 |
| 163 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.69312730 |
| 164 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.68795834 |
| 165 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.68583531 |
| 166 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.68481648 |
| 167 | NCOR_22424771_ChIP-Seq_293T_Human | 0.67947569 |
| 168 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.67143542 |
| 169 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.66400217 |
| 170 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.66296140 |
| 171 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.66098343 |
| 172 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.65758727 |
| 173 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.65384137 |
| 174 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.65251797 |
| 175 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.65099424 |
| 176 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.65099424 |
| 177 | STAT3_23295773_ChIP-Seq_U87_Human | 0.64431579 |
| 178 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.64306185 |
| 179 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.63348608 |
| 180 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.62771414 |
| 181 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.62158551 |
| 182 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.62140969 |
| 183 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.61150439 |
| 184 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.60375823 |
| 185 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.60224910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.35337458 |
| 2 | MP0005360_urolithiasis | 5.23010772 |
| 3 | MP0008260_abnormal_autophagy | 4.41645360 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.92261151 |
| 5 | MP0003646_muscle_fatigue | 3.70552874 |
| 6 | MP0003724_increased_susceptibility_to | 3.69370190 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.69159223 |
| 8 | MP0005365_abnormal_bile_salt | 3.65276843 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.38758702 |
| 10 | MP0003656_abnormal_erythrocyte_physiolo | 3.04694444 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.86139805 |
| 12 | MP0003303_peritoneal_inflammation | 2.73337653 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.51397457 |
| 14 | MP0002332_abnormal_exercise_endurance | 2.34272599 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 2.25353057 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.23567728 |
| 17 | MP0004130_abnormal_muscle_cell | 2.22977745 |
| 18 | MP0005451_abnormal_body_composition | 2.14643656 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 2.13196072 |
| 20 | MP0001545_abnormal_hematopoietic_system | 2.13196072 |
| 21 | MP0000751_myopathy | 2.13094263 |
| 22 | MP0003436_decreased_susceptibility_to | 2.10583765 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.10337957 |
| 24 | MP0002132_abnormal_respiratory_system | 2.08932847 |
| 25 | MP0006035_abnormal_mitochondrial_morpho | 2.05772224 |
| 26 | MP0000749_muscle_degeneration | 2.01572144 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 2.00611708 |
| 28 | MP0003252_abnormal_bile_duct | 1.98763551 |
| 29 | MP0004147_increased_porphyrin_level | 1.94276300 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.92216283 |
| 31 | MP0005332_abnormal_amino_acid | 1.91003953 |
| 32 | MP0009840_abnormal_foam_cell | 1.90776776 |
| 33 | MP0005075_abnormal_melanosome_morpholog | 1.88977613 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.84988293 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.84016711 |
| 36 | MP0003011_delayed_dark_adaptation | 1.83524971 |
| 37 | MP0002419_abnormal_innate_immunity | 1.78720723 |
| 38 | MP0004270_analgesia | 1.74039597 |
| 39 | MP0005083_abnormal_biliary_tract | 1.71978723 |
| 40 | MP0003186_abnormal_redox_activity | 1.67526431 |
| 41 | MP0001529_abnormal_vocalization | 1.66751089 |
| 42 | MP0004215_abnormal_myocardial_fiber | 1.66560062 |
| 43 | MP0002269_muscular_atrophy | 1.62581487 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.61338024 |
| 45 | MP0004036_abnormal_muscle_relaxation | 1.59914334 |
| 46 | MP0002398_abnormal_bone_marrow | 1.59291205 |
| 47 | MP0003329_amyloid_beta_deposits | 1.56716199 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 1.56103113 |
| 49 | MP0003195_calcinosis | 1.53894111 |
| 50 | MP0005266_abnormal_metabolism | 1.53269871 |
| 51 | MP0000609_abnormal_liver_physiology | 1.52862141 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48701694 |
| 53 | MP0005025_abnormal_response_to | 1.48177245 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.48137604 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.47027055 |
| 56 | MP0002722_abnormal_immune_system | 1.46980865 |
| 57 | MP0000747_muscle_weakness | 1.46248243 |
| 58 | MP0001800_abnormal_humoral_immune | 1.45959527 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.45445401 |
| 60 | MP0003880_abnormal_central_pattern | 1.45340398 |
| 61 | MP0004484_altered_response_of | 1.45042206 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.42659544 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.41968315 |
| 64 | MP0005330_cardiomyopathy | 1.40985543 |
| 65 | MP0005620_abnormal_muscle_contractility | 1.40977175 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.38431730 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 1.38277703 |
| 68 | MP0009785_altered_susceptibility_to | 1.37089745 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.35141006 |
| 70 | MP0001819_abnormal_immune_cell | 1.33298921 |
| 71 | MP0004087_abnormal_muscle_fiber | 1.32394235 |
| 72 | MP0000685_abnormal_immune_system | 1.31881100 |
| 73 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30814322 |
| 74 | MP0004859_abnormal_synaptic_plasticity | 1.30571008 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.27522848 |
| 76 | MP0002971_abnormal_brown_adipose | 1.25524259 |
| 77 | MP0002106_abnormal_muscle_physiology | 1.25510611 |
| 78 | MP0005535_abnormal_body_temperature | 1.25244655 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.24745116 |
| 80 | MP0000759_abnormal_skeletal_muscle | 1.22692489 |
| 81 | MP0005670_abnormal_white_adipose | 1.22641024 |
| 82 | MP0002723_abnormal_immune_serum | 1.21941999 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.19050695 |
| 84 | MP0000716_abnormal_immune_system | 1.18704035 |
| 85 | MP0002429_abnormal_blood_cell | 1.17600769 |
| 86 | MP0002405_respiratory_system_inflammati | 1.17475240 |
| 87 | MP0003828_pulmonary_edema | 1.16512559 |
| 88 | MP0003137_abnormal_impulse_conducting | 1.15522959 |
| 89 | MP0006276_abnormal_autonomic_nervous | 1.14696283 |
| 90 | MP0004883_abnormal_blood_vessel | 1.13896578 |
| 91 | MP0002452_abnormal_antigen_presenting | 1.13231931 |
| 92 | MP0001905_abnormal_dopamine_level | 1.10910363 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 1.10589947 |
| 94 | MP0003866_abnormal_defecation | 1.08930932 |
| 95 | MP0001666_abnormal_nutrient_absorption | 1.08547431 |
| 96 | MP0002254_reproductive_system_inflammat | 1.05213490 |
| 97 | MP0006082_CNS_inflammation | 1.04830628 |
| 98 | MP0008961_abnormal_basal_metabolism | 1.03819531 |
| 99 | MP0000703_abnormal_thymus_morphology | 1.03155886 |
| 100 | MP0000604_amyloidosis | 1.01948833 |
| 101 | MP0002822_catalepsy | 1.01254334 |
| 102 | MP0005671_abnormal_response_to | 1.00993074 |
| 103 | MP0009764_decreased_sensitivity_to | 1.00374955 |
| 104 | MP0003635_abnormal_synaptic_transmissio | 1.00120319 |
| 105 | MP0004043_abnormal_pH_regulation | 0.99917704 |
| 106 | MP0002102_abnormal_ear_morphology | 0.98345816 |
| 107 | MP0009278_abnormal_bone_marrow | 0.98033687 |
| 108 | MP0005369_muscle_phenotype | 0.96202484 |
| 109 | MP0000750_abnormal_muscle_regeneration | 0.95995077 |
| 110 | MP0004808_abnormal_hematopoietic_stem | 0.95165861 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.93314338 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.92776591 |
| 113 | MP0008469_abnormal_protein_level | 0.92049972 |
| 114 | MP0003868_abnormal_feces_composition | 0.91904431 |
| 115 | MP0009763_increased_sensitivity_to | 0.91395693 |
| 116 | MP0004085_abnormal_heartbeat | 0.91347310 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.91257662 |
| 118 | MP0002972_abnormal_cardiac_muscle | 0.90124364 |
| 119 | MP0005387_immune_system_phenotype | 0.90109782 |
| 120 | MP0001790_abnormal_immune_system | 0.90109782 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.90070773 |
| 122 | MP0003690_abnormal_glial_cell | 0.89843080 |
| 123 | MP0004084_abnormal_cardiac_muscle | 0.89803483 |
| 124 | MP0002063_abnormal_learning/memory/cond | 0.88731134 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.87337996 |
| 126 | MP0000858_altered_metastatic_potential | 0.86942969 |
| 127 | MP0001440_abnormal_grooming_behavior | 0.86905189 |
| 128 | MP0009333_abnormal_splenocyte_physiolog | 0.86337887 |
| 129 | MP0002572_abnormal_emotion/affect_behav | 0.85659577 |
| 130 | MP0004142_abnormal_muscle_tone | 0.85547562 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.84749794 |
| 132 | MP0001851_eye_inflammation | 0.84571182 |
| 133 | MP0001486_abnormal_startle_reflex | 0.84127089 |
| 134 | MP0004381_abnormal_hair_follicle | 0.84011024 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.83196953 |
| 136 | MP0006292_abnormal_olfactory_placode | 0.82639393 |
| 137 | MP0000598_abnormal_liver_morphology | 0.82539596 |
| 138 | MP0009697_abnormal_copulation | 0.82111124 |
| 139 | MP0010155_abnormal_intestine_physiology | 0.81595050 |
| 140 | MP0004233_abnormal_muscle_weight | 0.81465209 |
| 141 | MP0009745_abnormal_behavioral_response | 0.81034996 |
| 142 | MP0010368_abnormal_lymphatic_system | 0.80976412 |
| 143 | MP0002064_seizures | 0.79688300 |
| 144 | MP0002166_altered_tumor_susceptibility | 0.79141765 |
| 145 | MP0008872_abnormal_physiological_respon | 0.78406318 |
| 146 | MP0005164_abnormal_response_to | 0.77112403 |
| 147 | MP0002734_abnormal_mechanical_nocicepti | 0.76760758 |
| 148 | MP0005394_taste/olfaction_phenotype | 0.76504870 |
| 149 | MP0005499_abnormal_olfactory_system | 0.76504870 |
| 150 | MP0004924_abnormal_behavior | 0.76382422 |
| 151 | MP0005386_behavior/neurological_phenoty | 0.76382422 |
| 152 | MP0008874_decreased_physiological_sensi | 0.75859616 |
| 153 | MP0002970_abnormal_white_adipose | 0.75588686 |
| 154 | MP0009046_muscle_twitch | 0.74960083 |
| 155 | MP0008057_abnormal_DNA_replication | 0.74125152 |
| 156 | MP0000372_irregular_coat_pigmentation | 0.73419739 |
| 157 | MP0001915_intracranial_hemorrhage | 0.72527910 |
| 158 | MP0005334_abnormal_fat_pad | 0.72513137 |
| 159 | MP0000920_abnormal_myelination | 0.71765628 |
| 160 | MP0005448_abnormal_energy_balance | 0.70456928 |
| 161 | MP0008775_abnormal_heart_ventricle | 0.70225989 |
| 162 | MP0005452_abnormal_adipose_tissue | 0.69823318 |
| 163 | MP0005187_abnormal_penis_morphology | 0.69570777 |
| 164 | MP0002272_abnormal_nervous_system | 0.69036478 |
| 165 | MP0001663_abnormal_digestive_system | 0.68784956 |
| 166 | MP0005058_abnormal_lysosome_morphology | 0.67274303 |
| 167 | MP0001764_abnormal_homeostasis | 0.67083328 |
| 168 | MP0002127_abnormal_cardiovascular_syste | 0.65630210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Microcytic anemia (HP:0001935) | 5.35918076 |
| 2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 5.19787341 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 5.15322110 |
| 4 | Hypochromic anemia (HP:0001931) | 4.91853109 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.62365706 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.18788924 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.05038437 |
| 8 | Prolonged bleeding time (HP:0003010) | 4.01240164 |
| 9 | Gingival bleeding (HP:0000225) | 3.97322811 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 3.95518306 |
| 11 | Ketosis (HP:0001946) | 3.86866100 |
| 12 | Abnormal hemoglobin (HP:0011902) | 3.85276472 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.73161324 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.65568280 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.65155146 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 3.54074910 |
| 17 | Slow saccadic eye movements (HP:0000514) | 3.52939183 |
| 18 | Polycythemia (HP:0001901) | 3.52724773 |
| 19 | Xanthomatosis (HP:0000991) | 3.52628202 |
| 20 | Toxemia of pregnancy (HP:0100603) | 3.45440216 |
| 21 | Ketoacidosis (HP:0001993) | 3.42725195 |
| 22 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.42038352 |
| 23 | Hyperammonemia (HP:0001987) | 3.41463765 |
| 24 | Hyperglycinuria (HP:0003108) | 3.34818945 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.31180628 |
| 26 | Cholelithiasis (HP:0001081) | 3.30814100 |
| 27 | Abnormal platelet volume (HP:0011876) | 3.30568953 |
| 28 | Myositis (HP:0100614) | 3.29815164 |
| 29 | Hyperlipoproteinemia (HP:0010980) | 3.26283431 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.24494097 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.24494097 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 3.21634295 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.15881766 |
| 34 | Increased serum pyruvate (HP:0003542) | 3.15295307 |
| 35 | Abnormality of glycolysis (HP:0004366) | 3.15295307 |
| 36 | Ragged-red muscle fibers (HP:0003200) | 3.13854685 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.12715909 |
| 38 | Hyperventilation (HP:0002883) | 3.10238149 |
| 39 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.09860062 |
| 40 | Gout (HP:0001997) | 3.09240696 |
| 41 | Epistaxis (HP:0000421) | 3.08926720 |
| 42 | Abnormal gallbladder morphology (HP:0012437) | 3.08713155 |
| 43 | Hypolipoproteinemia (HP:0010981) | 3.07170334 |
| 44 | Increased mean platelet volume (HP:0011877) | 3.03850002 |
| 45 | Postural instability (HP:0002172) | 3.01754069 |
| 46 | Orchitis (HP:0100796) | 3.01050487 |
| 47 | Myoglobinuria (HP:0002913) | 2.99857290 |
| 48 | Hyperglycinemia (HP:0002154) | 2.97458197 |
| 49 | Prolonged partial thromboplastin time (HP:0003645) | 2.95606943 |
| 50 | Urticaria (HP:0001025) | 2.92709950 |
| 51 | Cerebral edema (HP:0002181) | 2.92441628 |
| 52 | Difficulty running (HP:0009046) | 2.90929822 |
| 53 | T lymphocytopenia (HP:0005403) | 2.86749644 |
| 54 | Visual hallucinations (HP:0002367) | 2.84118098 |
| 55 | Calf muscle hypertrophy (HP:0008981) | 2.82843492 |
| 56 | Encephalitis (HP:0002383) | 2.77429702 |
| 57 | Complement deficiency (HP:0004431) | 2.76790342 |
| 58 | Acute encephalopathy (HP:0006846) | 2.75081715 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.73984391 |
| 60 | Optic neuritis (HP:0100653) | 2.73984391 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.69948168 |
| 62 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.69726844 |
| 63 | Stomatitis (HP:0010280) | 2.68429950 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.67392144 |
| 65 | Metabolic acidosis (HP:0001942) | 2.66210072 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.65528740 |
| 67 | Muscle fiber inclusion bodies (HP:0100299) | 2.65490414 |
| 68 | Muscle stiffness (HP:0003552) | 2.63482674 |
| 69 | Recurrent fungal infections (HP:0002841) | 2.62556361 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.61408617 |
| 71 | Cholecystitis (HP:0001082) | 2.61408617 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.59756219 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.54828744 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54828744 |
| 75 | Orthostatic hypotension (HP:0001278) | 2.54139816 |
| 76 | Hyperbilirubinemia (HP:0002904) | 2.53073802 |
| 77 | Petechiae (HP:0000967) | 2.52506180 |
| 78 | Lethargy (HP:0001254) | 2.52466905 |
| 79 | Skin nodule (HP:0200036) | 2.50779219 |
| 80 | Abnormality of the lower motor neuron (HP:0002366) | 2.49758387 |
| 81 | Multiple enchondromatosis (HP:0005701) | 2.47866135 |
| 82 | Rhabdomyolysis (HP:0003201) | 2.45838370 |
| 83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.45731511 |
| 84 | Gingivitis (HP:0000230) | 2.45559971 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.45267414 |
| 86 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.44662055 |
| 87 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44660496 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.43162037 |
| 89 | Increased muscle lipid content (HP:0009058) | 2.36816683 |
| 90 | Peritonitis (HP:0002586) | 2.35562020 |
| 91 | Recurrent skin infections (HP:0001581) | 2.34962032 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.33287961 |
| 93 | Poikilocytosis (HP:0004447) | 2.32536429 |
| 94 | Hypoglycemic coma (HP:0001325) | 2.31600971 |
| 95 | Acute necrotizing encephalopathy (HP:0006965) | 2.31503920 |
| 96 | Vomiting (HP:0002013) | 2.30011907 |
| 97 | Paralysis (HP:0003470) | 2.29820511 |
| 98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.29425618 |
| 99 | Abnormality of macrophages (HP:0004311) | 2.28959804 |
| 100 | Hepatoblastoma (HP:0002884) | 2.26869411 |
| 101 | Hyperuricemia (HP:0002149) | 2.26784236 |
| 102 | Increased purine levels (HP:0004368) | 2.26784236 |
| 103 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.26340625 |
| 104 | Epidermoid cyst (HP:0200040) | 2.26252226 |
| 105 | Obstructive lung disease (HP:0006536) | 2.26219282 |
| 106 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26219282 |
| 107 | Acanthocytosis (HP:0001927) | 2.25515859 |
| 108 | EMG: myopathic abnormalities (HP:0003458) | 2.24739377 |
| 109 | Sudden death (HP:0001699) | 2.23720934 |
| 110 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.22605040 |
| 111 | Hyporeflexia of lower limbs (HP:0002600) | 2.22537544 |
| 112 | Papillary thyroid carcinoma (HP:0002895) | 2.21782148 |
| 113 | Status epilepticus (HP:0002133) | 2.21677739 |
| 114 | Abnormality of the intrinsic pathway (HP:0010989) | 2.21216195 |
| 115 | Abnormality of the gallbladder (HP:0005264) | 2.20755573 |
| 116 | Muscle fiber splitting (HP:0003555) | 2.20561293 |
| 117 | Leukocytosis (HP:0001974) | 2.20419452 |
| 118 | Nemaline bodies (HP:0003798) | 2.20346509 |
| 119 | Osteomalacia (HP:0002749) | 2.20024260 |
| 120 | Inflammation of the large intestine (HP:0002037) | 2.19525681 |
| 121 | Episodic fever (HP:0001954) | 2.19384942 |
| 122 | Abnormality of the Achilles tendon (HP:0005109) | 2.17653925 |
| 123 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16772894 |
| 124 | Keratoconjunctivitis (HP:0001096) | 2.16213045 |
| 125 | Chest pain (HP:0100749) | 2.15571562 |
| 126 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14275261 |
| 127 | Round ear (HP:0100830) | 2.13415824 |
| 128 | Abnormality of the common coagulation pathway (HP:0010990) | 2.12896374 |
| 129 | Abnormality of serum amino acid levels (HP:0003112) | 2.11924308 |
| 130 | Long clavicles (HP:0000890) | 2.11221533 |
| 131 | Malnutrition (HP:0004395) | 2.10398403 |
| 132 | Abnormality of lateral ventricle (HP:0030047) | 2.10305245 |
| 133 | Abnormality of purine metabolism (HP:0004352) | 2.10197970 |
| 134 | Generalized myoclonic seizures (HP:0002123) | 2.09836887 |
| 135 | Thrombophlebitis (HP:0004418) | 2.08814414 |
| 136 | Gastrointestinal inflammation (HP:0004386) | 2.08744690 |
| 137 | Myopathic facies (HP:0002058) | 2.08359024 |
| 138 | Abnormality of the corticospinal tract (HP:0002492) | 2.08201610 |
| 139 | Neurofibrillary tangles (HP:0002185) | 2.07529249 |
| 140 | Myotonia (HP:0002486) | 2.07343279 |
| 141 | Arterial thrombosis (HP:0004420) | 2.04194125 |
| 142 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02225127 |
| 143 | Progressive macrocephaly (HP:0004481) | 2.00993705 |
| 144 | Reticulocytosis (HP:0001923) | 2.00627630 |
| 145 | Increased serum ferritin (HP:0003281) | 2.00448777 |
| 146 | Cerebral hemorrhage (HP:0001342) | 2.00372690 |
| 147 | Abnormality of T cells (HP:0002843) | 2.00095116 |
| 148 | Abnormal cartilage morphology (HP:0002763) | 1.99673736 |
| 149 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96941533 |
| 150 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96941533 |
| 151 | Purpura (HP:0000979) | 1.96676531 |
| 152 | Anorexia (HP:0002039) | 1.96386775 |
| 153 | Delayed CNS myelination (HP:0002188) | 1.96286043 |
| 154 | Meningitis (HP:0001287) | 1.93717021 |
| 155 | Cellulitis (HP:0100658) | 1.93434775 |
| 156 | Cutaneous photosensitivity (HP:0000992) | 1.93002447 |
| 157 | Abnormality of methionine metabolism (HP:0010901) | 1.92144546 |
| 158 | Recurrent viral infections (HP:0004429) | 1.91889958 |
| 159 | Hepatic necrosis (HP:0002605) | 1.91372215 |
| 160 | Joint hemorrhage (HP:0005261) | 1.89786360 |
| 161 | Panhypogammaglobulinemia (HP:0003139) | 1.89437237 |
| 162 | Amyotrophic lateral sclerosis (HP:0007354) | 1.89309627 |
| 163 | Cerebral inclusion bodies (HP:0100314) | 1.88586079 |
| 164 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.87358197 |
| 165 | Abnormality of the calf musculature (HP:0001430) | 1.86231620 |
| 166 | Spontaneous abortion (HP:0005268) | 1.85813356 |
| 167 | Subaortic stenosis (HP:0001682) | 1.85332287 |
| 168 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.85332287 |
| 169 | Increased connective tissue (HP:0009025) | 1.85015050 |
| 170 | Sensorimotor neuropathy (HP:0007141) | 1.83973834 |
| 171 | Menorrhagia (HP:0000132) | 1.83385329 |
| 172 | Pustule (HP:0200039) | 1.77795596 |
| 173 | Type 1 muscle fiber predominance (HP:0003803) | 1.77285092 |
| 174 | Upper motor neuron abnormality (HP:0002127) | 1.75005978 |
| 175 | Abnormality of reticulocytes (HP:0004312) | 1.73939701 |
| 176 | Viral hepatitis (HP:0006562) | 1.73255363 |
| 177 | Childhood onset (HP:0011463) | 1.71485519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K3 | 4.30340669 |
| 2 | GRK5 | 3.39569510 |
| 3 | MAP2K4 | 3.06670480 |
| 4 | MAP3K9 | 2.96824835 |
| 5 | BCKDK | 2.96072945 |
| 6 | MAP3K11 | 2.92281738 |
| 7 | RIPK4 | 2.68983580 |
| 8 | OBSCN | 2.51240604 |
| 9 | GRK6 | 2.45606762 |
| 10 | PHKG1 | 2.43391543 |
| 11 | PHKG2 | 2.43391543 |
| 12 | EIF2AK1 | 2.42339970 |
| 13 | LATS2 | 2.41231803 |
| 14 | GRK7 | 2.36785595 |
| 15 | TAOK2 | 2.32341196 |
| 16 | PRPF4B | 2.17334973 |
| 17 | MARK1 | 2.14932622 |
| 18 | ERN1 | 2.01919367 |
| 19 | MOS | 1.98796568 |
| 20 | BLK | 1.94675410 |
| 21 | KSR2 | 1.89442039 |
| 22 | MAP3K3 | 1.88588066 |
| 23 | MAP3K4 | 1.87993627 |
| 24 | PDK4 | 1.84914888 |
| 25 | PDK3 | 1.84914888 |
| 26 | PTK2B | 1.83180167 |
| 27 | MAPK12 | 1.78553460 |
| 28 | CDK12 | 1.78012751 |
| 29 | IRAK4 | 1.73377513 |
| 30 | BMPR2 | 1.72189990 |
| 31 | SYK | 1.71665884 |
| 32 | TYRO3 | 1.69429518 |
| 33 | MUSK | 1.68424470 |
| 34 | PLK2 | 1.66392189 |
| 35 | DYRK2 | 1.59951087 |
| 36 | MAP4K1 | 1.57908307 |
| 37 | MAP3K1 | 1.57649166 |
| 38 | PIM1 | 1.57177215 |
| 39 | EPHA4 | 1.53713065 |
| 40 | FES | 1.52238555 |
| 41 | ERBB4 | 1.52100175 |
| 42 | MAP3K6 | 1.50996262 |
| 43 | IKBKE | 1.50388066 |
| 44 | ADRBK2 | 1.50260575 |
| 45 | PINK1 | 1.47225795 |
| 46 | TYK2 | 1.47114092 |
| 47 | CSK | 1.46848722 |
| 48 | PAK6 | 1.45809131 |
| 49 | PIK3CG | 1.44777058 |
| 50 | TAOK1 | 1.43188633 |
| 51 | DYRK3 | 1.41299113 |
| 52 | STK4 | 1.37420540 |
| 53 | MARK2 | 1.33532787 |
| 54 | MAPK13 | 1.33423885 |
| 55 | ZAP70 | 1.30437060 |
| 56 | MAP2K7 | 1.29771556 |
| 57 | NTRK1 | 1.26291427 |
| 58 | BTK | 1.23336572 |
| 59 | JAK2 | 1.22818078 |
| 60 | TGFBR2 | 1.22418502 |
| 61 | CSF1R | 1.21775910 |
| 62 | SGK2 | 1.20638124 |
| 63 | DYRK1B | 1.19643970 |
| 64 | ARAF | 1.18947330 |
| 65 | HCK | 1.18618696 |
| 66 | JAK3 | 1.18027393 |
| 67 | GRK1 | 1.17035560 |
| 68 | MARK3 | 1.15739084 |
| 69 | TTN | 1.15702128 |
| 70 | MAP3K7 | 1.14076118 |
| 71 | MAPK7 | 1.13768258 |
| 72 | KSR1 | 1.09799173 |
| 73 | PRKAA1 | 1.09474862 |
| 74 | YES1 | 1.06625463 |
| 75 | SCYL2 | 1.03739361 |
| 76 | PRKAA2 | 1.03148189 |
| 77 | LYN | 1.02722944 |
| 78 | SGK3 | 1.01496291 |
| 79 | MAP3K13 | 1.00208093 |
| 80 | TNK2 | 1.00088063 |
| 81 | DMPK | 0.99524584 |
| 82 | TXK | 0.99420253 |
| 83 | MATK | 0.97989469 |
| 84 | TBK1 | 0.97463413 |
| 85 | ABL2 | 0.97101438 |
| 86 | NTRK2 | 0.96508111 |
| 87 | MAP3K2 | 0.96190884 |
| 88 | CLK1 | 0.94677079 |
| 89 | OXSR1 | 0.92510605 |
| 90 | PAK3 | 0.90090110 |
| 91 | TAOK3 | 0.89884853 |
| 92 | PKN1 | 0.88207082 |
| 93 | NME1 | 0.87647886 |
| 94 | RAF1 | 0.86418719 |
| 95 | TRIB3 | 0.84973268 |
| 96 | CDK6 | 0.82041699 |
| 97 | CSNK1G2 | 0.81262859 |
| 98 | CAMK4 | 0.79814299 |
| 99 | DYRK1A | 0.75080191 |
| 100 | IRAK2 | 0.75026627 |
| 101 | TEC | 0.74745448 |
| 102 | CAMKK2 | 0.73881590 |
| 103 | TESK2 | 0.73416432 |
| 104 | IRAK1 | 0.73007726 |
| 105 | CAMK1G | 0.72441688 |
| 106 | DAPK2 | 0.71545273 |
| 107 | LATS1 | 0.71541319 |
| 108 | MAP4K2 | 0.71179910 |
| 109 | NEK1 | 0.71058259 |
| 110 | MAP3K12 | 0.69738151 |
| 111 | MAP2K6 | 0.69191251 |
| 112 | SGK223 | 0.68371784 |
| 113 | SGK494 | 0.68371784 |
| 114 | FGFR3 | 0.68197919 |
| 115 | PLK3 | 0.65585243 |
| 116 | CAMK2A | 0.63820287 |
| 117 | MAP3K5 | 0.63371992 |
| 118 | NEK9 | 0.63210168 |
| 119 | PDK2 | 0.62416209 |
| 120 | BMX | 0.60620348 |
| 121 | EPHA3 | 0.60497685 |
| 122 | LCK | 0.59510229 |
| 123 | NTRK3 | 0.59486342 |
| 124 | KIT | 0.59295749 |
| 125 | MAPK4 | 0.59226533 |
| 126 | WNK1 | 0.58753607 |
| 127 | LRRK2 | 0.57871148 |
| 128 | MAPK11 | 0.57837315 |
| 129 | RET | 0.57785208 |
| 130 | CSNK1G3 | 0.57371624 |
| 131 | CAMK1D | 0.57134780 |
| 132 | ADRBK1 | 0.57120507 |
| 133 | PIK3CA | 0.56887459 |
| 134 | CDK19 | 0.56461184 |
| 135 | RPS6KA4 | 0.55131330 |
| 136 | FGR | 0.54561009 |
| 137 | JAK1 | 0.53646522 |
| 138 | PDK1 | 0.53111541 |
| 139 | ITK | 0.52385246 |
| 140 | STK39 | 0.51084783 |
| 141 | STK10 | 0.50634478 |
| 142 | CDK15 | 0.48945986 |
| 143 | SGK1 | 0.47170111 |
| 144 | CDK5 | 0.46946795 |
| 145 | GSK3A | 0.45990279 |
| 146 | ACVR1B | 0.45630497 |
| 147 | CDK14 | 0.44854931 |
| 148 | ERBB2 | 0.44527830 |
| 149 | SIK2 | 0.43301516 |
| 150 | CDK18 | 0.43290360 |
| 151 | TTK | 0.43200499 |
| 152 | MAPKAPK3 | 0.42844488 |
| 153 | MINK1 | 0.42570752 |
| 154 | MAP3K10 | 0.42274062 |
| 155 | RPS6KC1 | 0.42017722 |
| 156 | RPS6KL1 | 0.42017722 |
| 157 | PRKACG | 0.40212728 |
| 158 | PDPK1 | 0.40114877 |
| 159 | RPS6KA5 | 0.39467013 |
| 160 | FYN | 0.39158621 |
| 161 | STK11 | 0.38064553 |
| 162 | SIK1 | 0.37541906 |
| 163 | MAP2K1 | 0.36902943 |
| 164 | PRKACA | 0.36718505 |
| 165 | CDK11A | 0.36654183 |
| 166 | CSNK1G1 | 0.36539886 |
| 167 | MAP3K14 | 0.36467644 |
| 168 | EPHB1 | 0.36297048 |
| 169 | CAMK2G | 0.36119167 |
| 170 | BRAF | 0.35646076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.39750368 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07716751 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.96559419 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.87409294 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.83246742 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.77718062 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.72368154 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.66006862 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64039905 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61691343 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.45446806 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42996446 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39474662 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.36944563 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.36713727 |
| 16 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.32976025 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.29474168 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28767394 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 2.20504211 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18871638 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16481493 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.07038169 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06200496 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95742450 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95337782 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.94454835 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92698631 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.89761003 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.81760620 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.80085923 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79935201 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79660192 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72050311 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70805302 |
| 35 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.68184573 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.65280772 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.64020972 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63774509 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.62660242 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.62626039 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.60320556 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.59419428 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48740225 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41890431 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40547570 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39776749 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39058528 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38223693 |
| 49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.29839392 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 1.23753823 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 1.21357237 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20252334 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20159844 |
| 54 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.19587045 |
| 55 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.19490323 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19063799 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16892760 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15992109 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14866997 |
| 60 | Measles_Homo sapiens_hsa05162 | 1.14128895 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12719609 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12262449 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12161169 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12153135 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10491514 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08587553 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07419844 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05526006 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05427677 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04406479 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04369484 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.02988039 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02958065 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 1.02230730 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97457179 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97219060 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.97079333 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95396306 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93447303 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92363008 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90859462 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90623948 |
| 83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89895401 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87574594 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87233637 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.87100674 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.85340049 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84913646 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82843353 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81954050 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81927878 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81493185 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81129502 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80623914 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79965788 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79841645 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.79352309 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76719082 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76714476 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76579654 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76332245 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.76324028 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76220474 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74524742 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72536406 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72199139 |
| 107 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70855594 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.68300946 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68233005 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67944601 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67499372 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.66822514 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65011836 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64739575 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64677477 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62815040 |
| 117 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62157226 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61049730 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59361293 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57042287 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54749329 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54396487 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54151648 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52801398 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52718879 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51372899 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50717946 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.49006415 |
| 129 | GABAergic synapse_Homo sapiens_hsa04727 | 0.48795518 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48262119 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47929978 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.46973663 |
| 133 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46308186 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45467589 |
| 135 | Lysine degradation_Homo sapiens_hsa00310 | 0.45045124 |
| 136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44879240 |
| 137 | Nicotine addiction_Homo sapiens_hsa05033 | 0.43925230 |
| 138 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43000743 |
| 139 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41212262 |
| 140 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40440687 |
| 141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39543618 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39178879 |
| 143 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38850121 |
| 144 | Shigellosis_Homo sapiens_hsa05131 | 0.37886759 |
| 145 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37252535 |
| 146 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37111223 |
| 147 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.36054641 |
| 148 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31368237 |
| 149 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31363313 |
| 150 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30914111 |
| 151 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30733504 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30097352 |
| 153 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.29248336 |
| 154 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28432290 |
| 155 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27136738 |
| 156 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.26898919 |
| 157 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.24909891 |
| 158 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.24340012 |
| 159 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22835638 |
| 160 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22214684 |
| 161 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.21990687 |
| 162 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.21890617 |
| 163 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19492647 |
| 164 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.16162795 |
| 165 | Long-term potentiation_Homo sapiens_hsa04720 | 0.15407349 |

